Orlistat Responsive Obesity Therapeutics
1. Xenical patent expiration
Treatment: NA
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US6004996 (Pediatric) | CHEPLAPHARM | Tetrahydrolipstatin containing compositions |
Jul, 2018
(7 years ago) | |
| US6004996 | CHEPLAPHARM | Tetrahydrolipstatin containing compositions |
Jan, 2018
(8 years ago) | |
Drugs and Companies using ORLISTAT ingredient
Market Authorisation Date: 23 April, 1999
Dosage: CAPSULE
More Information on Dosage
XENICAL family patents
